Clinical trials

3

Search and review clinical trials. Use filters to narrow results by trial status, phase, treatment, biological sex and sponsor.

Condition / disease
Location
Status: Not yet recruiting

Intestinal Microbiota Transplantation for Treating Advanced Tumor Cachexia

This project is a prospective, multicenter, single-arm, phase II clinical study aimed at evaluating the efficacy and safety of fecal microbiota transplantation (FMT) in treating advanced tumor cachexia.

Participants needed: 66
Trial details
Phase: Phase 2Age: 18+Biological sex: AllType: InterventionalSponsor: Hua JiangUpdated: Apr 16, 2026
Eligibility criteria

Pre-advanced or advanced tumor cachexia stage. [+3]

Any condition that affects gastrointestinal absorption, such as difficulty in sw... [+8]

Status: Recruiting

FMT+ QL1706+Bevacizumab+ XELOX as First-line Treatment for Advanced MSS-type Colon Cancer With Liver Metastasis

The investigators plan to initiate a prospective, multicenter, phase II study, recruiting 30 patients with advanced colon cancer patients with liver metastasis who have not received prior treatment. This study plans to reconstruct intestinal microecology through fecal microbiota transplantation (FMT), and combine with QL1706+Bevacizumab+XELOX to enhance the anti-tumor immune effect at the same time, thereby improving the prognosis of colon cancer patients with liver metastasis.

Participants needed: 30
Trial details
Phase: Phase 2Age: 18-75Biological sex: AllType: InterventionalSponsor: Hua JiangUpdated: Jan 2, 2026Locations: 1
Eligibility criteria

Histological or cytological confirmed advanced colon cancer with liver metastasi... [+6]

Suffered from other malignancies in the past 5 years, excluding cured basal cell... [+16]

Status: Recruiting

Laparoscopic or Abdominal Radical Hysterectomy for Cervical Cancer(Stage IA1 With LVSI, IA2)

The purpose of this study is to confirm whether there is a difference between laparoscopic radical hysterectomy (LRH) and abdominal radical hysterectomy (ARH) in patient survival for Cervical Cancer (Stage IA1 with LVSI, IA2)

Participants needed: 690
Trial details
Age: 21-70Biological sex: FemaleType: InterventionalSponsor: Hua JiangUpdated: Nov 10, 2021Locations: 1
Eligibility criteria

Clinical diagnosis of squamous carcinoma of the cervix, adenocarcinoma, squamous... [+8]

Those who are contraindicated for various surgeries and cannot undergo surgery. [+3]